Description
Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors, incorporating a fatty-acid moiety to extend systemic persistence. Approximate molecular formula: C221H342N46O68; molecular weight: approximately 4731.4 g/mol; CAS 2381089-83-2. The complete amino acid sequence has not been fully disclosed in public literature.
Research on Retatrutide has examined its combined agonism at GIP, GLP-1, and glucagon receptors, and downstream effects on hepatic and adipose metabolic signaling pathways in animal and clinical research models.
Supplied as a lyophilized powder for reconstitution, each batch is analyzed by HPLC and mass spectrometry to confirm identity and purity.
For laboratory research use only. Not for human or veterinary use, and not approved for any clinical or diagnostic application.
